International Study Helps Support FDA Approval of HIV Drug for Newborns
|
The FDA recently approved dolutegravir, a widely-used HIV
treatment, to suppress HIV in infants and young children. UC San Diego
research helped ... |
HIV prevention drug hailed as breakthrough, but who gets access?
Lenacapavir, a twice-a-year injection could transform HIV prevention, but it will not be available to all. View article...